Search Results

Displaying Results 1-1 of 1 "'VYGR'"

May 14, 2026, 09:00 ET A Unique Klotho-based Anti-Aging Therapy to Be Introduced at a Premier Longevity Forum: Inside Avaí Bio's Cell-Based Platform Approach

and more durable publicly listed biotechnology platforms in the cell-therapy-adjacent universe.Voyager Therapeutics, Inc. (NASDAQ: VYGR) focuses on applying its knowledge of human genetics to advance neurogenetic medicines, with a program pipeline that includes therapies for Alzheimer's

More news about: Equity Insider


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.